Lack of coverage for fertility services will be a huge obstacle for people eager to try Casgevy or a second sickle cell cure awaiting U.S. approval.
Comments
(._.)
There's nothing here…
Lack of coverage for fertility services will be a huge obstacle for people eager to try Casgevy or a second sickle cell cure awaiting U.S. approval.